145
Views
1
CrossRef citations to date
0
Altmetric
Original Research

The Search for Cyclooxygenase-2 (COX-2) Inhibitors for the Treatment of Inflammation Disease: An in-silico Study

ORCID Icon, ORCID Icon, , , , & show all
Pages 783-791 | Published online: 12 Apr 2022

Figures & data

Table 1 The Pharmacophore Models

Table 2 The Parameter and GH Score Obtained for Pharmacophore Model NPX-8

Figure 1 Display the pharmacophore features of (R)-naproxen, in which hydrophobic, negative ion, and hydrogen bond acceptors were assigned as yellow, brown, and red arrows, respectively.

Figure 1 Display the pharmacophore features of (R)-naproxen, in which hydrophobic, negative ion, and hydrogen bond acceptors were assigned as yellow, brown, and red arrows, respectively.

Figure 2 The area under curve (AUC) of receiver operating characteristic plot (ROC) of NPX-8.

Figure 2 The area under curve (AUC) of receiver operating characteristic plot (ROC) of NPX-8.

Figure 3 (A) Superimposed of (R)-naproxen between X-ray (green) and docked (blue) conformations with RMSD 0.71 Å. (B) The interaction of (R)-naproxen in the cavity of COX-2.

Figure 3 (A) Superimposed of (R)-naproxen between X-ray (green) and docked (blue) conformations with RMSD 0.71 Å. (B) The interaction of (R)-naproxen in the cavity of COX-2.

Figure 4 The molecular structures of best-docked hit molecules.

Figure 4 The molecular structures of best-docked hit molecules.

Figure 5 The interactions of Lig_1805/ZINC103584272, Lig_553/ZINC408573132, Lig_680/ZINC103584263, and Lig_2006/ZINC19324645, each with COX-2.

Figure 5 The interactions of Lig_1805/ZINC103584272, Lig_553/ZINC408573132, Lig_680/ZINC103584263, and Lig_2006/ZINC19324645, each with COX-2.